1636 related articles for article (PubMed ID: 17557708)
1. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
2. Comparison of colchicine, dapsone, triamcinolone, and diphenhydramine therapy for the treatment of brown recluse spider envenomation: a double-blind, controlled study in a rabbit model.
Elston DM; Miller SD; Young RJ; Eggers J; McGlasson D; Schmidt WH; Bush A
Arch Dermatol; 2005 May; 141(5):595-7. PubMed ID: 15897381
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of topical nitroglycerin in a New Zealand white rabbit model of brown recluse spider envenomation.
Lowry BP; Bradfield JF; Carroll RG; Brewer K; Meggs WJ
Ann Emerg Med; 2001 Feb; 37(2):161-5. PubMed ID: 11174233
[TBL] [Abstract][Full Text] [Related]
4. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
[TBL] [Abstract][Full Text] [Related]
5. Changes in hematological, hemostatic and biochemical parameters induced experimentally in rabbits by Loxosceles gaucho spider venom.
Tavares FL; Sousa-e-Silva MC; Santoro ML; Barbaro KC; Rebecchi IM; Sano-Martins IS
Hum Exp Toxicol; 2004 Oct; 23(10):477-86. PubMed ID: 15553173
[TBL] [Abstract][Full Text] [Related]
6. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
7. Brown spider envenomation.
Peterson ME
Clin Tech Small Anim Pract; 2006 Nov; 21(4):191-3. PubMed ID: 17265904
[TBL] [Abstract][Full Text] [Related]
8. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
9. Transfusion medicine illustrated: intravascular hemolysis with brown recluse spider envenomation.
Blackall DP
Transfusion; 2004 Nov; 44(11):1543. PubMed ID: 15504156
[No Abstract] [Full Text] [Related]
10. Brown spider dermonecrotic toxin directly induces nephrotoxicity.
Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S
Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484
[TBL] [Abstract][Full Text] [Related]
11. Brown recluse spider envenomation: dermatologic application of hyperbaric oxygen therapy.
Tutrone WD; Green KM; Norris T; Weinberg JM; Clarke D
J Drugs Dermatol; 2005; 4(4):424-8. PubMed ID: 16004015
[TBL] [Abstract][Full Text] [Related]
12. Brown spiders and loxoscelism.
da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
[TBL] [Abstract][Full Text] [Related]
13. [Changes in hemostasis of dogs with acute lymphoblastic leukemia].
Mischke R; Freund M; Leinemann-Fink T; Eisenberger B; Casper J; Nolte I
Berl Munch Tierarztl Wochenschr; 1998 Feb; 111(2):53-9. PubMed ID: 9513298
[TBL] [Abstract][Full Text] [Related]
14. Brown recluse spider envenomation.
Furbee RB; Kao LW; Ibrahim D
Clin Lab Med; 2006 Mar; 26(1):211-26, ix-x. PubMed ID: 16567232
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
[TBL] [Abstract][Full Text] [Related]
16. Brown recluse spider bites to the head: three cases and a review.
Leach J; Bassichis B; Itani K
Ear Nose Throat J; 2004 Jul; 83(7):465-70. PubMed ID: 15372917
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulopathy in dogs with shock induced by injection of heartworm extract.
Kitoh K; Watoh K; Kitagawa H; Sasaki Y
Am J Vet Res; 1994 Nov; 55(11):1542-7. PubMed ID: 7879977
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
19. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
20. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.
Olrik Berthelsen L; Thuri Kristensen A; Wiinberg B; Tranholm M
Thromb Res; 2009 Sep; 124(4):490-7. PubMed ID: 19525002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
